Su Zuopeng

Dr. Su Zuopeng

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2019 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
FXFulin Xu
Fulin Xu
GSGang Shen
Gang Shen
SZSu Zuopeng
Su Zuopeng
ZHZijian He
Zijian He
LYLutao Yuan
Lutao Yuan
Background: Glibenclamide is a widely used sulfonylurea drug prescribed to treat type II diabetes mellitus. Previous studies have demonstrated that glibenclamide has neuroprotective effects in central nervous system injury. However, the exact mechanism by which glibenclamide acts on the blood–brain barrier (BBB) after intracerebral hemorrhage (ICH) remains unclear. The purpose of this study was to validate the neuroprotective effects of glibenclamide on ICH and to explore the mechanisms underlying these effects.Methods: We investigated the effects of glibenclamide on experimental ICH using the autologous blood infusion model. Glibenclamide was administrated either immediately or 2 hr after ICH. Brain edema was quantified using the wet–dry method 3 days after injury. BBB integrity was evaluated by Evans Blue extravasation and degradation of the tight junction protein zona occludens‐1 (ZO‐1). mRNA levels of inflammatory cytokines were determined by quantitative polymerase chain reaction. Activation of the nucleotide‐binding oligomerization domain‐like receptor with a pyrin domain 3 (NLRP3) inflammasome and cell viability were also measured in cerebral microvascular endothelial b.End3 cells exposed to hemin. Neurological changes were evaluated by the Garcia score and rotarod test.Results: After ICH, the brain water content, Evans Blue extravasation, and inflammatory cytokines decreased significantly in the ipsilateral hemisphere of the experimental compared to the vehicle group. Glibenclamide treatment and NLRP3 knockdown significantly reduced hemin‐induced activation of the NLRP3 inflammasome, release of extracellular lactate dehydrogenase, apoptosis, and loss of ZO‐1 in b.End3 cells. However, NLRP3 knockdown abolished the protective effect of glibenclamide.Conclusion: Glibenclamide maintained BBB integrity in experimental ICH by inhibiting the activation of the NLRP3 inflammasome in microvessel endothelial cells. Our findings will contribute to elucidating the pharmacological mechanism of action of glibenclamide and to developing a novel therapy for clinical ICH.

20 December 2011 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YZYouxin Zhou
Youxin Zhou
SZSu Zuopeng
Su Zuopeng
YHYulun Huang
Yulun Huang
TSTing Sun
Ting Sun
SCSansong Chen
Sansong Chen
ZDZiwei Du
Ziwei Du
Background: Zfx is a zinc finger protein of the Zfy family, whose members are highly conserved in vertebrates. Zfx is a shared transcriptional regulator of both embryonic stem cells (ESC) and hematopoietic stem cells (HSC), which suggests a common genetic basis of self-renewal in embryonic and adult stem cells. The level of Zfx expression correlates with aggressiveness and severity in many cancer types, including prostate cancer, breast cancer, and leukemia. However, the importance of Zfx in human glioma is largely unknown. In the present study, we examined the role of Zfx in human glioma. Methods: We detected expression levels of Zfx mRNA in U251 cells, U87 cells, U373 cells, and A172 cells by semi-quantitative RT-PCR. To analyze the expression of Zfx mRNA in glioma tissues, we performed real-time quantitative PCR on 35 pathologically confirmed glioma samples (Grade I-4cases, Grade II-13cases, Grade III-11cases, and Grade IV-7cases) and on 5 noncancerous brain tissue samples. We used lentivirus-mediated small interfering RNAs (siRNAs) to knock down Zfx expression in the human malignant glioma cell line U251. Changes in Zfx target gene expression were determined by real-time RT-PCR. Cell proliferation was examined by a High Content Screening assay. DNA synthesis in proliferating cells was determined by BrdU incorporation. Cell cycle distribution and apoptosis were detected by flowcytometric analysis. Results: We discovered that Zfx mRNA was expressed in U251 cells, U87 cells, U373 cells, and A172 cells. The expression level of Zfx is significantly higher in gliomas compared to noncancerous brain tissue. Using a lentivirus-based RNAi approach, Zfx expression was significantly inhibited in human glioblastoma U251 cells. The effects of Zfx knockdown on cell proliferation, cell cycle distribution, and apoptosis were assessed. Inhibition of Zfx expression in U251 cells by RNAi significantly impaired cell proliferation, increased apoptosis, and arrested cells in S phase. Conclusions: The results of our study demonstrate that the Zfx gene is highly expressed in glioma tissue and in glioma cell lines. Furthermore, Zfx may play a critical role in cell proliferation, cell cycle distribution, and apoptosis of human malignant glioma cells.

28 November 2024 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
YLYongsheng Liu
Yongsheng Liu
LCLize Cai
Lize Cai
HWHao Wang
Hao Wang
LYLin Yao
Lin Yao
YWYue Wu
Yue Wu
YZYouxin Zhou
Youxin Zhou

15 October 2024 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
YLYongxia Li
Yongxia Li
GSGang Shen
Gang Shen
JDJiarui Du
Jiarui Du
WDWei Dai
Wei Dai
SZSu Zuopeng
Su Zuopeng
Background: As antioxidant and anti-inflammatory agents, carbonic anhydrase inhibitors can exert potentially useful therapeutic effects following central nervous system trauma, including intracerebral hemorrhage (ICH). However, the therapeutic efficacy of ethoxyzolamide (ETZ) as a novel carbonic anhydrase inhibitor for ICH has not yet been determined. Methods: An autologous blood injection method was used to establish ICH models, which were then used to establish the effects of intraperitoneal injection of ETZ on ICH. Neuronal damage, apoptotic protein expression, oxidative and inflammatory factor content, microglia marker Iba-1 positivity, hepatic and renal pathological changes, and serum concentrations of hepatic and renal function indices were assessed by Nissl staining, western blotting, enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, hematoxylin and eosin (HE) staining, and automatic biochemical analysis in brain tissues. Results: The ICH group showed massive hemorrhagic foci; significant increases in brain water content, modified mouse neurological deficit scoring (mNSS) score, pro-apoptotic protein expression, oxidative factors, pro-inflammatory factors, and Iba-1 positivity; and significant reductions in Nissl body size, anti-apoptotic protein expression, and antioxidant factors, all of which were reversed by ETZ in a dose-dependent manner. ETZ has a good biosafety profile with no significant burden on the human liver or kidneys. The Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway was mildly activated in ICH mice, and was further increased after ETZ injection. Molecular docking experiments revealed that ETZ could dock onto the Nrf2-binding domain of keap1. Conclusions: ETZ, as a novel carbonic anhydrase inhibitor, further activated the Keap1/Nrf2 pathway by docking with the Nrf2-binding domain of keap1, thereby exerting antioxidant, anti-inflammatory, anti-apoptotic, and cerebral neuroprotective effects in ICH mice.

12 March 2025 in Animal Models and Experimental Medicine
Verified
Journal Article
Open access
WDWei Dai
Wei Dai
YLYongxia Li
Yongxia Li
JDJiarui Du
Jiarui Du
GSGang Shen
Gang Shen
MFMeimei Fan
Meimei Fan
FYFang Yuan
Fang Yuan
Background: Intracerebral hemorrhage (ICH) remains a devastating neurological disorder with limited therapeutic options. Neural stem cell (NSC)‐based therapies have emerged as a potential regenerative approach, yet the molecular mechanisms regulating NSC behavior require further elucidation. The role of miR‐21 in NSC differentiation and proliferation during ICH recovery remains unexplored. Methods: In vitro NSC cultures were analyzed for miR‐21 expression dynamics during differentiation via qPCR. Lentiviral overexpression and knockdown of miR‐21 were employed to assess its functional impact. The SOX2/LIN28‐let‐7 pathway was investigated using Western blot, luciferase reporter assays, and immunofluorescence. In vivo, miR‐21‐overexpressing NSCs were transplanted into a murine ICH model, with neurogenesis evaluated by immunostaining and neurological recovery assessed through behavioral tests (mNSS, rotarod). Results: miR‐21 expression significantly increased during NSC differentiation, correlating with reduced SOX2 levels. Mechanistically, miR‐21 directly targeted SOX2, disrupting the SOX2/LIN28‐let‐7 axis to promote NSC proliferation and lineage commitment. In ICH mice, transplantation of miR‐21‐overexpressing NSCs enhanced neurogenesis and improved motor coordination and neurological deficits at 28 days post‐transplantation. Conclusions: Our findings identify miR‐21 as a critical regulator of NSC plasticity through SOX2/LIN28‐let‐7 signaling, highlighting its therapeutic potential for enhancing neuroregeneration and functional recovery in ICH. Targeting miR‐21 may represent a novel strategy to optimize NSC‐based therapies for hemorrhagic stroke.

9 April 2012 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
YZYou-Xin Zhou
You-Xin Zhou
XCXiong-Hui Chen
Xiong-Hui Chen
XXXue-Shun Xie
Xue-Shun Xie
YHYulun Huang
Yulun Huang
ZXZhi-Mou Xue
Zhi-Mou Xue
ZDZi-Wei Du
Zi-Wei Du